Literature DB >> 25164473

Retrospective database study to assess the economic impact of hip fracture in the United Kingdom.

Dimitra Lambrelli1, Russel Burge, Mireia Raluy-Callado, Shih-Yin Chen, Ning Wu, Michael J Schoenfeld.   

Abstract

OBJECTIVE: Publications containing recent, real-world data on the economic impact of hip fractures in the UK are lacking. This retrospective electronic medical records database analysis assessed medication and healthcare resource use, direct healthcare costs, and factors predicting increased resource use and costs in adult UK hip fracture patients.
METHODS: Data were obtained from the Clinical Practice Research Datalink linked to the Hospital Episode Statistics for adult patients hospitalized for their first hip fracture between January 1, 2006 and March 31, 2011 (index event); healthcare costs were calculated from the National Health Service perspective using 2011-2012 cost data.
RESULTS: Data from 8028 patients were analyzed. Resource use and costs were statistically significantly higher in the year following fracture (mean total [standard deviation (SD)] cost £7359 [£14,937]) compared with the year before fracture (mean total [SD] cost £3122 [£9435]; p < 0.001), and were similar to the total amount of the index hospitalization (mean total [SD] cost £8330 [£2627]). Multivariate regression analysis (using an estimated generalized linear model) showed that older age, male gender, higher comorbidity, osteoporosis, discharge to another institution compared with home, and pre-index hospitalization and outpatient visits were associated with increased post-index hospitalization healthcare costs (all p < 0.05).
CONCLUSIONS: Although we did not capture all pre- and post-index costs and healthcare utilization, this study provides important insights regarding the characteristics of patients with hip fracture, and information that will be useful in burden-of-illness and economic analyses.

Entities:  

Keywords:  Epidemiology; Healthcare costs; Healthcare resource use; Hip fractures

Mesh:

Year:  2014        PMID: 25164473     DOI: 10.3111/13696998.2014.959588

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


  7 in total

1.  Increased risk of bone fracture among patients with urinary calculi: a nationwide longitudinal population-based study.

Authors:  S-M Ou; Y-T Chen; C-J Shih; D-C Tarng
Journal:  Osteoporos Int       Date:  2014-12-19       Impact factor: 4.507

2.  Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.

Authors:  Sarah Davis; Emma Simpson; Jean Hamilton; Marrissa Martyn-St James; Andrew Rawdin; Ruth Wong; Edward Goka; Neil Gittoes; Peter Selby
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

3.  The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality.

Authors:  A Marques; Ó Lourenço; J A P da Silva
Journal:  Osteoporos Int       Date:  2015-05-19       Impact factor: 4.507

4.  Anticholinergic burden and fractures: a protocol for a methodological systematic review and meta-analysis.

Authors:  Jonas Reinold; Wiebke Schäfer; Lara Christianson; Francesco Barone-Adesi; Oliver Riedel; Federica Edith Pisa
Journal:  BMJ Open       Date:  2019-08-21       Impact factor: 2.692

5.  Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease.

Authors:  Federica Pisa; Jonas Reinold; Piia Lavikainen; Marjaana Koponen; Heidi Taipale; Antti Tanskanen; Jari Tiihonen; Sirpa Hartikainen; Anna-Maija Tolppanen
Journal:  Clin Epidemiol       Date:  2021-04-22       Impact factor: 4.790

6.  Validation of the Hospital Episode Statistics Outpatient Dataset in England.

Authors:  Joanna C Thorn; Emma Turner; Luke Hounsome; Eleanor Walsh; Jenny L Donovan; Julia Verne; David E Neal; Freddie C Hamdy; Richard M Martin; Sian M Noble
Journal:  Pharmacoeconomics       Date:  2016-02       Impact factor: 4.981

7.  Impact of hip fracture on hospital care costs: a population-based study.

Authors:  J Leal; A M Gray; D Prieto-Alhambra; N K Arden; C Cooper; M K Javaid; A Judge
Journal:  Osteoporos Int       Date:  2015-08-19       Impact factor: 4.507

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.